PixCell Medical Technologies is a privately held Israeli company developing cell-based point of care (POC) diagnostics devices.
PixCell's technology is based on Viscoelastic Focusing, a patented methodology,and on a proprietary microfluidic based disposable.
PixCell was founded by Prof. Max Herzberg, a leading figure in the biotech industry in Israel, and Dr. Avishay Bransky, an expert in microfluidics and the inventor of the Viscoelastic Focusing technology.
PixCell's first product, HemoScreen™, is a point of care complete blood count (CBC) system. It is CE marked, FDA cleared, and is currently being marketed in Europe.
PixCell's innovative technology is a powerful platform for developing portable diagnostic devices based on whole blood analysis.